Jilin Province Huinan Changlong Bio-pharmacy Company Limited Stock
Equities
8049
CNE100000130
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 HKD | +1.65% | 0.00% | +12.80% |
Sales 2022 | 842M 116M 909M | Sales 2023 | 842M 116M 909M | Capitalization | 835M 115M 902M |
---|---|---|---|---|---|
Net income 2022 | 194M 26.77M 210M | Net income 2023 | 148M 20.42M 160M | EV / Sales 2022 | -0.74 x |
Net cash position 2022 | 1.05B 145M 1.13B | Net cash position 2023 | 578M 79.72M 624M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
2.22
x | P/E ratio 2023 |
5.63
x | Employees | 848 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 23.02% |
1 day | +1.65% | ||
Current month | +6.32% | ||
1 month | +5.71% | ||
3 months | +7.56% | ||
6 months | +44.53% | ||
Current year | +12.80% |
Managers | Title | Age | Since |
---|---|---|---|
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Xiang Fu Xu
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Xiao Guang Zhang
BRD | Director/Board Member | 60 | 90-11-30 |
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.85 | +1.65% | 332 000 |
24-04-24 | 1.82 | -1.09% | 21,320 |
24-04-23 | 1.84 | +2.22% | 176,000 |
24-04-22 | 1.8 | 0.00% | 52,000 |
24-04-19 | 1.8 | -2.70% | 248,000 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 03:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.80% | 130M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+54.06% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+4.79% | 8.31B |
- Stock Market
- Equities
- 8049 Stock